Expert US stock balance sheet health analysis and debt sustainability metrics to assess financial stability and long-term risk for portfolio companies. Our fundamental analysis digs deep into financial statements to identify hidden risks that might not be obvious from headline numbers alone. We provide debt analysis, liquidity metrics, and solvency indicators for comprehensive financial health assessment. Understand balance sheet health with our comprehensive fundamental analysis and risk metrics for safer investing.
As of 2026-04-13, New York Times Company (The) (NYT) trades at a current price of $78.81, marking a 0.25% decline from the prior session close. This analysis evaluates the stock’s recent trading context, key technical levels, and potential near-term scenarios to help market participants understand prevailing trends for the media publisher. No recent earnings data is available for NYT as of this writing, so recent price action has been driven primarily by broad market flows and sector sentiment r
Can New York (NYT) Stock Beat the Market | Price at $78.81, Down 0.25% - Long Setup
NYT - Stock Analysis
3828 Comments
933 Likes
1
Kellum
Influential Reader
2 hours ago
Expert US stock credit rating analysis and default risk assessment to identify financial distress signals. We monitor credit markets to understand the health of companies and potential risks to equity holders.
👍 239
Reply
2
Courntey
Consistent User
5 hours ago
This feels like a beginning and an ending.
👍 210
Reply
3
Ezai
Active Reader
1 day ago
This feels like the beginning of a problem.
👍 127
Reply
4
Zody
Registered User
1 day ago
I don’t understand but I’m aware.
👍 178
Reply
5
Gaby
Community Member
2 days ago
This feels like I’m missing something obvious.
👍 261
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.